Vice President - Global Market Access, Cell Therapy
October 17
Description
• More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio is a late-stage biotechnology company redefining the transplant process by developing next-generation cell therapies with the goal of providing significantly better survival rates with dramatically fewer risks. • With our purified, high-precision investigational cell therapies we hope to not only replace patients' blood and immune systems with healthy ones, but also restore their lives. • The VP of Global Market Access will lead the development and execution of strategies that optimize patient access to Orca Bio’s cutting-edge cell therapies, focusing primarily on the US and EU regions. This role involves collaborating with cross-functional teams, stakeholders, and healthcare providers to navigate the complex market landscape.
Requirements
• Advanced degree in life sciences, business administration, or a related field; MBA preferred. • 15+ years in market access, with a focus on cell therapies or biologics, including leadership roles. Significant market building and launch experience required. Small company experience preferred. • In-depth understanding of the healthcare landscape, payer dynamics, and reimbursement processes, including inpatient/outpatient reimbursement, US payer value and pricing as well as EU HTA and coverage dynamics. • Strong analytical, strategic thinking, and communication skills. Proven ability to lead teams and manage complex projects. Proven ability to develop and enhance product value propositions with US and EU payer audiences. • Established relationships with key industry stakeholders and decision-makers across the US payer landscape.
Apply Now